Bicorsan Special Precautions

Procaterol HCl Hemihydrate syrup should be administered with care in the following patient: Patients with hyperthyroidism; can improve the severity of the disease.
Patients with heart disease; palpitations, arrhythmias, increased disease severity heart, and other symptoms can appear.
For patients with hypertension, an increase in higher blood pressure can occur.
Patients with diabetes mellitus; can improve the severity of the disease. Patients throughout pregnancy or patients suspected of being pregnant.
The main component of long-term bronchial asthma management is anti-inflammatory drugs such as an inhaled corticosteroid. Procaterol HCl Hemihydrate can only be used as adjunctive therapy for patients with symptoms that cannot be controlled with inhaled corticosteroids or other asthma drugs or based on the severity of the disease requiring treatment with Procaterol HCl Hemihydrate. Procaterol HCl Hemihydrate is not a substitute for inhaled corticosteroids and other antiinflammatory drugs; patients, patient supervisors, or other legally authorized persons should be advised not to reduce the dose of inhaled corticosteroids or to stop using inhaled corticosteroids and switch to monotherapy with Procaterol HCl Hemihydrate unless specifically recommended by doctors, even if the patient feels improvement in symptoms by using Procaterol HCl Hemihydrate.
Throughout the long-term management of bronchial asthma with Procaterol HCl Hemihydrate, patients can experience episodes of acute asthma. Patients, or patient supervisors, or other legally authorized persons should be instructed to use other drugs that are adequate in addition to Procaterol HCl Hemihydrate, such as inhaled stimulant β₂ short-acting drugs if acute asthma episodes occur during treatment with Procaterol HCl Hemihydrate. Additionally when the use of these drugs becomes increasingly often or the expected therapeutic effect is not observed with the initial dose of treatment, the patient's asthma may not be controlled enough. The patient, the patient's supervisor, or other people who are legally authorized should be instructed to consult a doctor immediately and receive adequate medication in this case. In addition, in conditions that can be life-threatening, anti-inflammatory treatment needs to be given at an adequate dose, such by increasing the dose of inhaled corticosteroids.
If the desired therapeutic effect of Procaterol HCl Hemihydrate Syrup cannot be achieved at the recommended dose, the drug should be discontinued.
The provision of Procaterol HCl Hemihydrate continuously in excessive amounts can cause cardiac arrhythmia and cardiac arrest. Special attention must be given to avoid giving drugs more than the recommended dose.
Appropriate dosage or other measures must be considered when prescribing Procaterol HCl Hemihydrate to elderly patients because elderly patients can be physiologically more sensitive to this drug than younger patients.
This drug can only be given to pregnant women or women who are suspected of being pregnant if the expected therapeutic benefits outweigh any possible risks. The safety of using this drug during pregnancy is unknown.
The breastfeeding process must be paused before starting treatment with Procaterol HCl Hemihydrate because Procaterol HCl Hemihydrate is also excreted through breast milk.
The safety of this drug in babies born with low weight and neonates is unknown. There is no clinical experience in babies born with low weight and neonates.
These drugs tend to be able to inhibit skin reactions in allergen testing. Procaterol HCl Hemihydrate administration must be stopped 12 hours before the test.
Damage to heart muscle tissue was observed in studies test animals; however, the damage has also been reported with the use of other β₂-adrenergic agonists.
Mesovarian leiomyoma has been observed in long term toxicity studies in test animals; however, these tumors are species-specific tumors and tend to form on long-term β₂-adrenergic agonists.
Patients should be instructed to keep the drug out of the reach of children to prevent accidental ingestion.